AKT1 and cancer: Additionally, the combination inhibited the migration and invasion of cancer cells, as evidenced by the migration assay, plus both drugs were previously found to inhibit the PI3K/AKT/mTOR axis, hence inhibiting EMT and cancer metastasis.